N-cyclohexyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidine-1-carboxamide

C15H24N4O2 — CID 110603715

IUPACN-cyclohexyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidine-1-carboxamide
SMILESCc1nnc(C2CCN(C(=O)NC3CCCCC3)CC2)o1
InChIInChI=1S/C15H24N4O2/c1-11-17-18-14(21-11)12-7-9-19(10-8-12)15(20)16-13-5-3-2-4-6-13/h12-13H,2-10H2,1H3,(H,16,20)
InChIKeyXCVVCDMWCWLOOA-UHFFFAOYSA-N
MW292.38 g/mol
LogP2.60
Rot. Bonds2

About N-cyclohexyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidine-1-carboxamide

N-cyclohexyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidine-1-carboxamide (PubChem CID 110603715) has the molecular formula C15H24N4O2 and a molecular weight of 292.38 g/mol. Its IUPAC name is N-cyclohexyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidine-1-carboxamide.

Molecular Properties

Compound NameN-cyclohexyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidine-1-carboxamide
PubChem CID110603715
Molecular FormulaC15H24N4O2
Molecular Weight292.38 g/mol
Exact Mass292.19
IUPAC NameN-cyclohexyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidine-1-carboxamide
SMILESCc1nnc(C2CCN(C(=O)NC3CCCCC3)CC2)o1
InChIInChI=1S/C15H24N4O2/c1-11-17-18-14(21-11)12-7-9-19(10-8-12)15(20)16-13-5-3-2-4-6-13/h12-13H,2-10H2,1H3,(H,16,20)
InChIKeyXCVVCDMWCWLOOA-UHFFFAOYSA-N
XLogP2.60
TPSA71.26 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds2
Heavy Atoms21
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500292.38
LogP ≤ 52.60
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Analyze N-cyclohexyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidine-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(oxan-4-yl)piperidine-1-carboxamide
CID 110612150
(3S)-N-cyclohexyl-3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]pyrrolidine-1-carboxamide
CID 51137817
N-cyclohexyl-4-[(5-methyl-1,3,4-oxadiazol-2-yl)methyl]piperazine-1-carboxamide
CID 110395570
N-(cyclohex-3-en-1-ylmethyl)-4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidine-1-carboxamide
CID 146149857
2-cyclohexyl-5-methyl-1,3,4-oxadiazole;methanamine
CID 143346929
N-cyclooctyl-4-(2H-tetrazol-5-yl)piperidine-1-carboxamide
CID 138047066
N-cycloheptylpiperidine-1-carboxamide
CID 54054704
N-cyclohexyl-4-(5-ethyl-1,3,4-thiadiazol-2-yl)piperidine-1-carboxamide
CID 30864319
4-(5-amino-4-methyl-1,2-oxazol-3-yl)-N-cyclopentylpiperidine-1-carboxamide
CID 53146814
trans-(1R,2R)-2-[4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]cyclohexan-1-ol
CID 95827633
2-(1-cyclopentylsulfonylpiperidin-4-yl)-5-methyl-1,3,4-oxadiazole
CID 110421409
(4-chlorophenyl)-[4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidin-1-yl]methanone
CID 59347461

Frequently Asked Questions

What is the IUPAC name of N-cyclohexyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidine-1-carboxamide?
The IUPAC name of N-cyclohexyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidine-1-carboxamide (CID 110603715) is N-cyclohexyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidine-1-carboxamide.
What is the SMILES notation for N-cyclohexyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidine-1-carboxamide?
The canonical SMILES for N-cyclohexyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidine-1-carboxamide is Cc1nnc(C2CCN(C(=O)NC3CCCCC3)CC2)o1.
What is the InChIKey of N-cyclohexyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidine-1-carboxamide?
The InChIKey is XCVVCDMWCWLOOA-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H24N4O2/c1-11-17-18-14(21-11)12-7-9-19(10-8-12)15(20)16-13-5-3-2-4-6-13/h12-13H,2-10H2,1H3,(H,16,20).
What are the key properties of N-cyclohexyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidine-1-carboxamide?
N-cyclohexyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidine-1-carboxamide has a molecular weight of 292.38 g/mol, XLogP of 2.60, 2 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-cyclohexyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)piperidine-1-carboxamide is sourced from PubChem (CID 110603715), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).